Clinical Trial Update: A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia [Phase 1]

View source ↗

Summary

Phase 1b trial of BHV-7000 in inherited erythromelalgia is enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Erythromelalgia

Drugs mentioned

• BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Familial Erythromelalgia | Phase 1 | Status: ENROLLING_BY_INVITATION